These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 28803748)
1. Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base. Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Holcomb K Gynecol Oncol; 2017 Nov; 147(2):296-301. PubMed ID: 28803748 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors. de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840 [TBL] [Abstract][Full Text] [Related]
3. Ovarian Yolk Sac Tumors; Does Age Matter? Faure Conter C; Xia C; Gershenson D; Hurteau J; Covens A; Pashankar F; Krailo M; Billmire D; Patte C; Fresneau B; Shaikh F; Stoneham S; Nicholson J; Murray M; Frazier AL Int J Gynecol Cancer; 2018 Jan; 28(1):77-84. PubMed ID: 29194189 [TBL] [Abstract][Full Text] [Related]
4. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors. Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810 [TBL] [Abstract][Full Text] [Related]
5. Trends in the surgical management of malignant ovarian germcell tumors. Nasioudis D; Mastroyannis SA; Latif NA; Ko EM Gynecol Oncol; 2020 Apr; 157(1):89-93. PubMed ID: 32008791 [TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of 12 cases of ovarian yolk sac tumor]. Liu J; Chu HJ; Shan YP; Song WJ; Chen AP Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450 [No Abstract] [Full Text] [Related]
10. Small Cell Carcinoma of the Ovary: A Rare Tumor With a Poor Prognosis. Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K Int J Gynecol Cancer; 2018 Jun; 28(5):932-938. PubMed ID: 29621125 [TBL] [Abstract][Full Text] [Related]
11. Ovarian Yolk Sac Tumor: The Experience of a Regional Cancer Center. Wang X; Ma Z; Li Y Int J Gynecol Cancer; 2016 Jun; 26(5):884-91. PubMed ID: 27104939 [TBL] [Abstract][Full Text] [Related]
12. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study. Seagle BL; Kanis M; Strohl AE; Shahabi S Gynecol Oncol; 2016 Dec; 143(3):636-641. PubMed ID: 27771166 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of patients with ovarian yolk sac tumors: a study in Chinese patients. Tong X; You Q; Li L; Cai L; Wang C; Zheng J Onkologie; 2008 Dec; 31(12):679-84. PubMed ID: 19060506 [TBL] [Abstract][Full Text] [Related]
14. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database. Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of patients with yolk sac tumors of the ovary. Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186 [TBL] [Abstract][Full Text] [Related]
16. Endodermal sinus tumor of the ovary: the Hacettepe University experience. Ayhan A; Taskiran C; Bozdag G; Altinbas S; Altinbas A; Yuce K Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):230-4. PubMed ID: 16026921 [TBL] [Abstract][Full Text] [Related]
17. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour. Satoh T; Aoki Y; Kasamatsu T; Ochiai K; Takano M; Watanabe Y; Kikkawa F; Takeshima N; Hatae M; Yokota H; Saito T; Yaegashi N; Kobayashi H; Baba T; Kodama S; Saito T; Sakuragi N; Sumi T; Kamura T; Yoshikawa H Eur J Cancer; 2015 Feb; 51(3):340-51. PubMed ID: 25559616 [TBL] [Abstract][Full Text] [Related]